MAL 
Singapore
Hong Kong
IndonesiaEQUINIX - Case study of Nanyang Biologics
About Equinix
Equinix (Nasdaq: EQIX) is the world’s digital infrastructure company. Digital leaders harness Equinix’s trusted platform to bring together and interconnect foundational infrastructure at software speed. Equinix enables organizations to access all the right places, partners and possibilities to scale with agility, speed the launch of digital services, deliver world-class experiences and multiply their value, while supporting their sustainability goals.
About Nanyang
Nanyang Biologics is an AI-driven biotech company dedicated to advancing drug discovery. By combining machine learning, high-performance computing and pharmaceutical expertise, the company accelerates research in cancer, metabolic disorders and neurodegenerative diseases. Through strategic partnerships, Nanyang Biologics continues to push the limits of AI-driven pharmaceutical innovation, optimizing drug development and reducing discovery timelines.